CLOs on the Move

Surgery Partners

www.surgerypartners.com

 
Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high-quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 31 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Spencer Clark
 SVP and General Counsel Profile
Roxanne Womack
 SVP, Chief Compliance Officer Profile
Spencer Clark
 VP and Senior Legal Counsel Profile
Kelly Whelan
 VP and Senior Legal Counsel, American and Eastern Groups Profile

Similar Companies

IVX Animal Health

IVX Animal Health is a Saint Joseph, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NAMSA North American Science Associates

NAMSA North American Science Associates, Inc. is a Northwood, OH-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Medical Business bureau

Medical Business bureau is a Park Ridge, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Parker HealthcareIT

Parker HealthcareIT is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fibrocell Science

Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.